LEO Pharma hands Bartle Bogle Hegarty global eczema awareness brief

leo pharma

Bartle Bogle Hegarty has won the global account for LEO Pharma for a chronic hand eczema disease awareness campaign after a competitive pitch.

The agency will launch the campaign in September at EADV (European Academy of Dermatology and Venereology) Congress in Milan.

LEO Pharma

Merete Kraemmer Christiansen, Senior Global Marketing Manager at LEO, said: “BBH won the pitch due to the team’s profound understanding of the barriers facing chronic hand eczema patients and their strong ability to visualise how LEO can raise awareness of the disease burden in a convincing and compelling way.”

Natalie Enniks, Business Lead and Partner at BBH London, said: “Chronic hand eczema is a painful and sometimes debilitating condition that has been made worse for many people during COVID because of the need for increased hand sanitisation. 

“We’re excited to develop a campaign to highlight and represent the extent of the problem for this often under-served condition.”

The win represents a further vote of confidence in BBH’s rapidly growing healthcare business. Clients in this area include Roche, Genentech, Servier, Takeda, Medtronic and Kyowa Kirin.

LEO Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries.

Its headquarters are in Ballerup, near Copenhagen The company is 100% integrated into a private foundation owned by the LEO Foundation.